Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410455 | SCV000487533 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger) | 2016-03-04 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000411996 | SCV000487534 | likely pathogenic | Peroxisome biogenesis disorder 1B | 2016-03-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001004319 | SCV001163200 | pathogenic | Peroxisome biogenesis disorder 1A (Zellweger); Peroxisome biogenesis disorder 1B | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001201668 | SCV001372750 | pathogenic | Zellweger spectrum disorders | 2024-01-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg959*) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of a Zellweger spectrum disorder (PMID: 27848944). ClinVar contains an entry for this variant (Variation ID: 371716). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV003319350 | SCV004024033 | pathogenic | not provided | 2023-02-02 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27848944, 34974531) |
Baylor Genetics | RCV003475982 | SCV004203256 | pathogenic | Heimler syndrome 1 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001201668 | SCV002076836 | pathogenic | Zellweger spectrum disorders | 2021-02-16 | no assertion criteria provided | clinical testing |